vs
信诺（CI）与Humana（HUM）财务数据对比。点击上方公司名可切换其他公司
信诺的季度营收约是Humana的2.2倍（$72.5B vs $32.5B），信诺净利率更高（1.8% vs -2.4%，领先4.2%），Humana同比增速更快（11.3% vs 10.4%），过去两年信诺的营收复合增速更高（12.5% vs 4.8%）
信诺集团是总部位于美国康涅狄格州布卢姆菲尔德的跨国营利性医疗管理及保险企业。旗下保险子公司主营医疗、牙科、失能、人寿、意外保险及相关产品服务，多数产品通过雇主及其他团体渠道销售。
Humana是总部位于美国肯塔基州路易斯维尔的营利性健康保险企业，为美国第四大健康保险服务商。2024年该公司位列《财富》美国500强第92位，是肯塔基州上榜企业中排名最高的一家。
CI vs HUM — 直观对比
营收规模更大
CI
是对方的2.2倍
$32.5B
营收增速更快
HUM
高出0.9%
10.4%
净利率更高
CI
高出4.2%
-2.4%
两年增速更快
CI
近两年复合增速
4.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $72.5B | $32.5B |
| 净利润 | $1.3B | $-796.0M |
| 毛利率 | 20.3% | — |
| 营业利润率 | 3.2% | -2.5% |
| 净利率 | 1.8% | -2.4% |
| 营收同比 | 10.4% | 11.3% |
| 净利润同比 | -17.1% | -14.9% |
| 每股收益（稀释后） | $4.64 | $-6.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CIHUM
| Q4 25 | $72.5B | $32.5B | ||
| Q3 25 | $69.7B | $32.6B | ||
| Q2 25 | $67.2B | $32.4B | ||
| Q1 25 | $65.5B | $32.1B | ||
| Q4 24 | $65.6B | $29.2B | ||
| Q3 24 | $63.7B | $29.4B | ||
| Q2 24 | $60.5B | $29.5B | ||
| Q1 24 | $57.3B | $29.6B |
净利润CIHUM
| Q4 25 | $1.3B | $-796.0M | ||
| Q3 25 | $2.0B | $195.0M | ||
| Q2 25 | $1.6B | $545.0M | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | $1.5B | $-693.0M | ||
| Q3 24 | $825.0M | $480.0M | ||
| Q2 24 | $1.6B | $679.0M | ||
| Q1 24 | $-212.0M | $741.0M |
毛利率CIHUM
| Q4 25 | 20.3% | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.7% | — | ||
| Q1 25 | 26.1% | — | ||
| Q4 24 | 25.3% | — | ||
| Q3 24 | 25.3% | — | ||
| Q2 24 | 26.5% | — | ||
| Q1 24 | 27.6% | — |
营业利润率CIHUM
| Q4 25 | 3.2% | -2.5% | ||
| Q3 25 | 3.7% | 1.2% | ||
| Q2 25 | 3.4% | 3.4% | ||
| Q1 25 | 3.0% | 6.3% | ||
| Q4 24 | 3.3% | -1.9% | ||
| Q3 24 | 4.0% | 2.5% | ||
| Q2 24 | 4.0% | 3.9% | ||
| Q1 24 | 3.9% | 4.2% |
净利率CIHUM
| Q4 25 | 1.8% | -2.4% | ||
| Q3 25 | 2.8% | 0.6% | ||
| Q2 25 | 2.4% | 1.7% | ||
| Q1 25 | 2.2% | 3.9% | ||
| Q4 24 | 2.3% | -2.4% | ||
| Q3 24 | 1.3% | 1.6% | ||
| Q2 24 | 2.7% | 2.3% | ||
| Q1 24 | -0.4% | 2.5% |
每股收益（稀释后）CIHUM
| Q4 25 | $4.64 | $-6.59 | ||
| Q3 25 | $6.98 | $1.62 | ||
| Q2 25 | $5.71 | $4.51 | ||
| Q1 25 | $4.85 | $10.30 | ||
| Q4 24 | $5.01 | $-5.73 | ||
| Q3 24 | $2.63 | $3.98 | ||
| Q2 24 | $5.45 | $5.62 | ||
| Q1 24 | $-0.97 | $6.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.7B | $19.9B |
| 总债务越低越好 | $30.9B | — |
| 股东权益账面价值 | $41.7B | $17.7B |
| 总资产 | $157.9B | $48.9B |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资CIHUM
| Q4 25 | $8.7B | $19.9B | ||
| Q3 25 | $6.9B | $22.1B | ||
| Q2 25 | $5.1B | $21.7B | ||
| Q1 25 | $9.1B | $22.1B | ||
| Q4 24 | $8.2B | $20.4B | ||
| Q3 24 | $6.8B | $24.1B | ||
| Q2 24 | $7.9B | $22.9B | ||
| Q1 24 | $9.5B | $22.6B |
总债务CIHUM
| Q4 25 | $30.9B | — | ||
| Q3 25 | $30.9B | — | ||
| Q2 25 | $26.5B | — | ||
| Q1 25 | $26.5B | — | ||
| Q4 24 | $28.9B | — | ||
| Q3 24 | $30.2B | — | ||
| Q2 24 | $30.2B | — | ||
| Q1 24 | $31.1B | — |
股东权益CIHUM
| Q4 25 | $41.7B | $17.7B | ||
| Q3 25 | $41.8B | $18.5B | ||
| Q2 25 | $40.2B | $18.2B | ||
| Q1 25 | $40.2B | $17.8B | ||
| Q4 24 | $41.0B | $16.4B | ||
| Q3 24 | $42.1B | $17.6B | ||
| Q2 24 | $41.3B | $16.7B | ||
| Q1 24 | $41.2B | $16.1B |
总资产CIHUM
| Q4 25 | $157.9B | $48.9B | ||
| Q3 25 | $157.9B | $49.7B | ||
| Q2 25 | $151.7B | $50.4B | ||
| Q1 25 | $150.7B | $50.9B | ||
| Q4 24 | $155.9B | $46.5B | ||
| Q3 24 | $157.6B | $50.0B | ||
| Q2 24 | $155.4B | $50.1B | ||
| Q1 24 | $153.1B | $50.1B |
负债/权益比CIHUM
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.66× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.71× | — | ||
| Q3 24 | 0.72× | — | ||
| Q2 24 | 0.73× | — | ||
| Q1 24 | 0.75× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.1B | $-1.7B |
| 自由现金流经营现金流 - 资本支出 | — | $-1.9B |
| 自由现金流率自由现金流/营收 | — | -5.7% |
| 资本支出强度资本支出/营收 | — | 0.6% |
| 现金转化率经营现金流/净利润 | 4.83× | — |
| 过去12个月自由现金流最近4个季度 | — | $375.0M |
8季度趋势，按日历期对齐
经营现金流CIHUM
| Q4 25 | $6.1B | $-1.7B | ||
| Q3 25 | $3.4B | $971.0M | ||
| Q2 25 | $-1.9B | $1.3B | ||
| Q1 25 | $1.9B | $331.0M | ||
| Q4 24 | $5.2B | $-528.0M | ||
| Q3 24 | $46.0M | $1.9B | ||
| Q2 24 | $265.0M | $1.2B | ||
| Q1 24 | $4.8B | $423.0M |
自由现金流CIHUM
| Q4 25 | — | $-1.9B | ||
| Q3 25 | — | $836.0M | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $236.0M | ||
| Q4 24 | — | $-682.0M | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $246.0M |
自由现金流率CIHUM
| Q4 25 | — | -5.7% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | — | 3.7% | ||
| Q1 24 | — | 0.8% |
资本支出强度CIHUM
| Q4 25 | — | 0.6% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.6% |
现金转化率CIHUM
| Q4 25 | 4.83× | — | ||
| Q3 25 | 1.73× | 4.98× | ||
| Q2 25 | -1.16× | 2.33× | ||
| Q1 25 | 1.36× | 0.27× | ||
| Q4 24 | 3.39× | — | ||
| Q3 24 | 0.06× | 3.87× | ||
| Q2 24 | 0.16× | 1.79× | ||
| Q1 24 | — | 0.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CI
| Network Pharmacy | $34.3B | 47% |
| Home Delivery And Specialty | $21.1B | 29% |
| Cigna Healthcare | $9.4B | 13% |
| Services | $4.5B | 6% |
| Other Pharmacy | $3.4B | 5% |
| Service Other | $144.0M | 0% |
HUM
| Insurance Segment | $31.3B | 96% |
| Other | $880.0M | 3% |
| Services | $292.0M | 1% |
